• P-ISSN 0973-7200 E-ISSN 2454-8405
  • Follow us

Journal of Pharmaceutical Research

Article

Evaluation of Anti-anxiety Activity of Passiflora Incarnata F ruit in Experimental Animal Models
  • VIEWS 124
  • PDF 93

Journal of Pharmaceutical Research

DOI: 10.18579/jopcr/v17.3.angel

Year: 2018, Volume: 17, Issue: 3, Pages: 1-7

Original Article

Evaluation of Anti-anxiety Activity of Passiflora Incarnata F ruit in Experimental Animal Models

Angel 1, Jyothi Y1,∗, Saif Ulla Khan2

1Department of Pharmacology, Krupanidhi College of Pharmacy, Carmelaram, Varthur Hobli, Bengaluru, Karnataka, India
2Department of Pharmacognosy, Krupanidhi College of Pharmacy, Varthur Hobli, Karnataka, Carmelaram, Bengaluru, India

*Corresponding Author
Email: [email protected]

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Objectives: Anxiety disorders are the most widespread mental health issues worldwide. Anxiety symptoms are prevalent in society, affecting not only the youth but also the elderly. While normal anxiety aids in dealing with challenges, excessive anxiety can be detrimental. This study aimed to assess the anxiolytic effects of aqueous Passiflora incarnata fruit extract in animal models. Methods: Phytochemical screening of Passiflora incarnata was conducted. The effects of Passiflora incarnata on reducing anxiety were examined using various well-established animal models, including the elevated plus maze, staircase, hole board, and light/dark model. Each group consisted of six animals and different doses of Passiflora incarnata (100, 200, and 400 mg/kg) were administered. Distilled water served as the control group, and diazepam (2 mg/kg) was used as the standard reference. Findings: Preliminary phytochemical screening revealed the presence of flavonoids, alkaloids and tannin and carbohydrates, proteins, steroids and terpenoids were found to be absent. These findings led to the conclusion that the medium (200 mg/kg) and high (400 mg/kg) doses exhibited notable anti-anxiety activity in comparison to the control group. Conversely, the low dose did not show any significant anxiolytic activity when compared to the control group. Novelty: Passiflora incarnata has the potential to serve as a natural psychotherapeutic agent for treating different anxiety-related disorders compared to existing therapies. This study shows encouraging results for the application of herbs in therapies for mental disorders, such as depression, anxiety, and insomnia.

Keywords: Passiflora incarnata, Phytochemical screening, Anti­anxiety

References

  2. Rawat PS. Select Your Doses & Potency. 2002.
  3. Poethke W, Schwarz C, Gerlach H. Contents of Passiflora bryonioides. Planta Medica. 1970;18:303–314. Available from: https://dx.doi.org/10.1055/s-0028-1099783
  4. Gavasheli NM, Moniava II, Eristavi LI. Aminoacids from Passiflora incarnata cultivated in the Georgian SSR. Khimiya Prirodnykh Soedinenii. 1974;10:266.
  5. Buchbauer G, Jirovetz L. Volatile Constituents of the Essential Oil of Passiflora incarnata L. Journal of Essential Oil Research. 1992;4(4):329–334. Available from: https://dx.doi.org/10.1080/10412905.1992.9698081
  6. Simmen U, Burkard W, Berger K, Schaffner W, Lundstrom K. Extracts and Constituents of Hypericum Perforatum Inhibit the Binding of Various Ligands to Recombinant Receptors Expressed with the Semliki Forest Virus System. Journal of Receptors and Signal Transduction. 1999;19(1-4):59–74. Available from: https://dx.doi.org/10.3109/10799899909036637
  7. Soulimani R, Younos C, Jarmouni S, Bousta D, Misslin R, Mortier F. Behavioural effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse. Journal of Ethnopharmacology. 1997;57(1):11–20. Available from: https://dx.doi.org/10.1016/s0378-8741(97)00042-1
  8. Schlede E. Oral acute toxic class method: OECD Test Guideline 423. Rapporti istisan. 2002;41:32–38. Available from: https://doi.org/10.1787/20745788
  9. Singh N, Kaur S, Bedi PM, Kaur D. Anxiolytic effects of Equisetum arvense Linn. extracts in mice. Indian Journal of Experimental Biology. 2011;49(5):352–358. Available from: https://pubmed.ncbi.nlm.nih.gov/21615059/
  11. Gupta V, Bansal P, Niazi J, Kaur G. Anti-anxiety Activity of Citrus paradisi var. star ruby Extracts. International Journal of Pharm Tech Research. 2010;2(3):1655–1662. Available from: https://sphinxsai.com/july-sept_2010_vol2.3/pharmtech/pharmtechvol2.3july-sept210/PT=02%20(1655-1657).pdf
  12. Rodgers RJ, Dalvi A. Anxiety, defence and the elevated plus-maze. Neuroscience & Biobehavioral Reviews. 1997;21(6):801–810. Available from: https://dx.doi.org/10.1016/s0149-7634(96)00058-9
  13. Yadav AV, Kawale LA, Nade VS. Effect of Morus alba L. (mulberry) leaves on anxiety in mice. Indian Journal of Pharmacology. 2008;40:32–36. Available from: https://doi.org/10.4103%2F0253-7613.40487
  14. Rahman H, Eswaraiah MC, Ramesh S, Rao BM. Study of anxiolytic activity of some essential oils used by inhalational exposure in mice. Scholars Journal of Applied Medical Sciences. 2013;1(1):1–4. Available from: https://www.saspublishers.com/article/5411/download/
  15. Hascoët M, Bourin M, Dhonnchadha BÁN. The mouse ligth-dark paradigm: A review. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2001;25(1):141–166. Available from: https://dx.doi.org/10.1016/s0278-5846(00)00151-2
  16. Simiand J, Keane PE, Morre M. The staircase test in mice: A simple and efficient procedure for primary screening of anxiolytic agents. Psychopharmacology. 1984;84(1):48–53. doi: 10.1007/bf00432023
  17. Rex A, Morgenstern E, Fink H. Anxiolytic-like effects of Kava-Kava in the elevated plus maze test—a comparison with diazepam. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2002;26(5):855–860. Available from: https://dx.doi.org/10.1016/s0278-5846(01)00330-x
  18. Faustino TT, Almeida RBd, Andreatini R. Medicinal plants for the treatment of generalized anxiety disorder: a review of controlled clinical studies. Revista Brasileira de Psiquiatria. 2010;32:429–436. Available from: https://dx.doi.org/10.1590/s1516-44462010005000026
  19. Wolfman C, Viola H, Paladini A, Dajas F, Medina JH. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora Coerulea. Pharmacology Biochemistry and Behavior. 1994;47(1):1–4. Available from: https://dx.doi.org/10.1016/0091-3057(94)90103-1
  20. Zanoli P, Avallone R, Baraldi M. Behavioral characterisation of the flavonoids apigenin and chrysin. Fitoterapia. 2000;71:S117–S123. Available from: https://dx.doi.org/10.1016/s0367-326x(00)00186-6
  21. Dhawan K, Kumar S, Sharma A. Anti-anxiety studies on extracts of Passiflora incarnata Linneaus. Journal of Ethnopharmacology. 2001;78(2-3):165–170. Available from: https://dx.doi.org/10.1016/s0378-8741(01)00339-7

Copyright

© 2018 Published by Krupanidhi College of Pharmacy. This is an open-access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/4.0/) 

  • 22 September 2024

Year: 2018, Volume: 17, Issue: 3


More articles

DON'T MISS OUT!

Subscribe now for latest articles and news.